BLAINJECTIONINJECTABLEPriority Review
Approved
Mar 1990
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Priority Review
Drug data last refreshed 20h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
ADAGEN (pegademase bovine) is a PEGylated enzyme replacement therapy administered via injection for the treatment of adenosine deaminase (ADA) deficiency, a rare inherited metabolic disorder. This biologic works by replacing the deficient enzyme, enabling patients with ADA-SCID to metabolize toxic metabolites that would otherwise accumulate and damage the immune system. It represents a critical bridge therapy for patients awaiting gene therapy or hematopoietic stem cell transplantation.
LOE Approaching
Mature ultra-rare disease product with modest team footprint and declining pipeline momentum as newer gene therapies emerge.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
ADAGEN careers are concentrated in rare disease management, patient advocacy, and specialty pharmacy coordination rather than traditional sales expansion. Professionals joining this team should expect a niche, highly specialized environment with minimal headcount growth and a focus on maintaining patient relationships and managed access rather than driving volume growth.
Brand Manager (Rare Disease)
Worked on ADAGEN at Leadiant Biosciences? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.